PRKCI and ovarian carcinoma: On the other hand, Wang et al. demonstrated that oncogenic PKCι unleashed YAP1 from its binding partner AMOT in cytoplasm, promoting the nuclear relocation and activation of YAP1 in ovarian cancer cells [23].